Natixis Advisors’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$800K Sell
28,063
-50
-0.2% -$1.08K ﹤0.01% 1566
2026
Q1
$322K Sell
28,113
-201
-0.7% -$2.83K ﹤0.01% 1636
2025
Q4
$407K Sell
28,314
-149
-0.5% -$2.58K ﹤0.01% 1498
2025
Q3
$539K Sell
28,463
-6,951
-20% -$115K ﹤0.01% 1470
2025
Q2
$759K Buy
35,414
+380
+1% +$5.65K ﹤0.01% 1376
2025
Q1
$459K Sell
35,034
-1,081
-3% -$16K ﹤0.01% 1471
2024
Q4
$485K Buy
+36,115
New +$581K ﹤0.01% 1480

Other funds holding OSCR

Natixis Advisors's OSCR Position: Q2 2026 in Review

Natixis Advisors reduced its Oscar Health (OSCR) stake by 0.18% in Q2 2026, selling an estimated $1.08K and leaving 28,063 shares worth $800K. The position accounts for ﹤0.01% of the portfolio, ranked #1566.

Natixis Advisors first reported a position in OSCR in Q4 2024 and has held it in 7 quarters since. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Natixis Advisors held 28,063 shares of Oscar Health worth $800K as of Q2 2026.
  • Natixis Advisors sold 50 Oscar Health shares in Q2 2026, an estimated $1.08K.
  • Oscar Health made up ﹤0.01% of Natixis Advisors's portfolio in Q2 2026, its #1566 holding.
  • Natixis Advisors first reported a position in Oscar Health in Q4 2024 and has held it in 7 quarters since.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.